01/06/2021 - 12:15 Portfolio Incendin reaches breakthrough in sustainable technology for fire safety Read more
28/05/2021 - 17:00 Financial Convocation of the annual and special general meeting of Gimv on June 30th, 2021 Read more
05/05/2021 - 07:30 Portfolio Gimv increases its interest in German GPNZ to further support and develop the dental platform in its growth ambitions Read more
04/05/2021 - 14:00 Portfolio Biotalys Earns Recognition in Fast Company’s 2021 World Changing Ideas Awards Read more
29/04/2021 - 07:30 Portfolio Projective Group, specialising in delivering (digital) change trajectories, partners up with Gimv for its further European expansion Read more
14/04/2021 - 07:30 Portfolio Gimv partners with Apraxon to support the company’s growth ambitions Read more
17/03/2021 - 07:40 Portfolio Gimv invests in Verkley, a specialist contractor in cable and pipeline networks for energy and water Read more
17/03/2021 - 07:30 Portfolio Consortium around EMERAM and Gimv to support German digital learning platform sofatutor in the next growth phase Read more
08/03/2021 - 17:45 Financial Gimv pioneers with a sustainable finance framework, resulting in the successful issue of a first sustainable bond Read more
15/02/2021 - 13:30 Corporate news 100x100 - CEO Koen Dejonckheere in conversation with Wassim Essebane Read more
29/01/2021 - 07:30 Financial Gimv announces share buyback in the context of a share purchase plan for its personnel Read more
21/01/2021 - 10:00 Portfolio Biotalys submits first protein-based biocontrol registration package to the EPA Read more
19/01/2021 - 14:30 Portfolio Gimv sells OTN Systems, a provider of telecommunication solutions for industrial markets, to listed Belden Inc. Read more
10/12/2020 - 11:00 Portfolio Cegeka and Citymesh join forces to form a fourth national operator in Belgium Read more
02/12/2020 - 07:30 Portfolio Gimv sells Itho Daalderop-Climate for Life - Dutch market leader in integrated sustainable solutions for energy-neutral living in the Benelux - to Parcom Read more
30/11/2020 - 08:00 Portfolio Gimv is founding investor of Kinaset Therapeutics in a USD 40m Series A round – funds used to develop novel therapeutics for respiratory diseases Read more
25/11/2020 - 09:00 Portfolio Kind Technologies acquires Martin Stolze for further growth within the horticulture greenhouse market Read more
19/11/2020 - 07:30 Portfolio Gimv invests in SynOx Therapeutics which raises EUR 37 million to develop emactuzumab for treatment of tenosynovial giant cell tumors Read more
11/11/2020 - 13:00 Portfolio ImCheck Presents at SITC First Clinical Demonstration of Gamma Delta T Cell Activation and Tumor Infiltration with Positive Safety for ICT01 Read more
